Theralink Technologies Inc (THER)

[learningcurve2020]

Wow are you lost. Those days are long gone. But Big Al remains. LOL

Sept. 27, 2018

[Bodhi_Trades]

THER

“In preparation for the trial and other pipeline developments, the Company has taken measures to clean its balance sheet, including recently retiring $900,000 in convertible, floorless debt. Management is currently in negotiations with its lenders and accredited investors to secure additional funding structured under attractive terms, including preferred stock and fixed-rate convertible debentures.”

https://www.otcmarkets.com/stock/THER/news/OncBioMune-Initiates-Phase-2-Clinical-Trial-of-Novel-Vaccine-as-Front-Line-Treatment-for-Prostate-Cancer?id=205204

[learningcurve2020]

.0009

[learningcurve2020]

Looks like they had some revenue. Why they choose this course with share structure, is beyond me??

[carusso]

Doesn’t look like it went down too well.

[learningcurve2020]

Big Al just filed maybe the longest form in history! Congrats!

[learningcurve2020]

"Oh, it's thirteen ten thousands"

Guy spills his drink.

LOL

[carusso]

So right…

[learningcurve2020]

How's that work when the CEO is sitting at a table at some event and the guy next to her says "Sounds like a nice business what's your share price?" I mean seriously, what the hell are they doing?

[learningcurve2020]

Someone just traded 45 cents. LOL

[learningcurve2020]

They still haven't changed the lineup.

https://theralink.com/investors/management-team

[learningcurve2020]

One more decimal point move and they'll be in Quantumania. LOL

[carusso]

Badly, Sadly…

[learningcurve2020]

How's it going here? LOL. Still somehow has a ten million dollar market cap. I guess that what billions of shares outstanding does.

[$on_myMind]

Looks like someone market sold 5 million into no support for no reason. I dont see rs. They are suppose to have nasdaq news with BACK soon per company

[learningcurve2020]

Looks like they got a cash infusion but still no merge.

[learningcurve2020]

Can you please show us your formula? Thanks.

[Jayzp]

Going to be in cents soon..may be next week.
Good news...with nasdaq merger

[learningcurve2020]

??

[carusso]

Can we raise the Ask here? Pitiful…

[carusso]

Rather you didn’t use that word, and I don’t agree. Never helps anything.

[norisknorewards]

busy spreading more misinformation again?

[learningcurve2020]

Never understood why Mick the CEO would try to sell a stock with billions of shares outstanding, you? They require a 1 for 500 reverse split to normalize. Then all the initial pain that comes with that so...

[carusso]

Skepticism is appropriate in sub-penny stocks. I just hope they succeed against the odds.


Better communication might help them…

[learningcurve2020]

Good post. It's possible it was just about timing although you'd think someone would've bought them instead of taking over another shell. I'm skeptical given Mick was trying to sell the story to retail with such poor share structure.

[carusso]

But public thinking is slowly changing demand toward more targeted treatments such as immunotherapy…

I hope the company succeeds for the sake of those who need less destructive cancer treatments than those that have prevailed thus far.

[carusso]

Well, you’re asking a kind of “rocket science” question from someone who is not in that field of science, and even so, there is probably some degree of protected “market intelligence” surrounding the answer. I think it is a cut-throat, competitive field, with those invested in maintaining the status quo soundly “in the money”. That the prior company might have failed on financial grounds despite having a workable idea, does not condemn them to my way of thinking. There is massive resistance to innovation in that field.

[learningcurve2020]

Welcome. And? Any answers?

[carusso]

Thanks.

[learningcurve2020]

Do your homework.

>>Theralink Technologies, Inc., formerly OncBioMune Pharmaceuticals, Inc. (the “Company”), was a clinical-stage biopharmaceutical company engaged in the development of novel cancer immunotherapy products, with a proprietary vaccine technology. On June 5, 2020, the Company acquired the assets (the “Asset Sale Transaction”) of Avant Diagnostics, Inc., a Nevada corporation established in 2009 (“Avant”) pursuant to the Asset Purchase Agreement dated May 12, 2020, between the Company and Avant (the “Asset Purchase Agreement”). Avant is a commercial-stage precision medicine and molecular data-generating company that focuses on the development and commercialization of a series of patented, proprietary data-generating assays that may provide important actionable information for physicians and patients, as well as biopharmaceutical companies, in the areas of oncology.

[carusso]

What previous company was that, if you don’t mind explaining it, and when did they “go bust”??

[learningcurve2020]

The question I asked here a while back that nobody replied to was what changed with their IP / product offering from when they were the previous company that went bust?

[carusso]

It will matter to me. I’m recently invested in this one. Their concept is sound in the cancer research; I’m
not well informed as to their process and how close they are to clinical goals.

[learningcurve2020]

The last massive reverse split already did all the damage leaving shareholders with 99.9% loses so another one won't matter. If they do merge with IMAC it'll likely end up the same thing where shares outstanding will look more normal. It's amazing to me "Al" was appointed CFO again even after the lashing shareholders took with him at the helm of Onc.

[carusso]

I think not - merger with BACK (IMAC).

[carusso]

RS is a very bad word.

[learningcurve2020]

When is the next whopping reverse split to bring the share price and outstanding to reasonable figures?

[carusso]

Not if you read their story?

[surf1944]

Spamming clown this is garbage being acquired by another garbage company.

[learningcurve2020]

Do they still teach writing?

[Jayzp]

Check tomm. You would cry.
Why u waste ur time here on this board when you have no idea where this can reach.

[learningcurve2020]

LOL...That's just lazy writing.

[Jayzp]

You are still buying it this stock? And tell all negative, i know what you are up

[learningcurve2020]

Almost $5 of interest today. Can't make it up.

[learningcurve2020]

You guys can attack me all you want. I take it as a badge of honor and a sign you all know I'm right.

[carusso]

Thanks.

[learningcurve2020]

You do understand they have many billions of shares outstanding, right?

So long Mick! Great show. LOL

Golden, Colorado, June 27, 2023 (GLOBE NEWSWIRE) — Theralink Technologies, Inc. (OTC: THER) (“Theralink” or the “Company”), a precision oncology company with a novel phosphoprotein and protein assay for breast cancer in the process of merging with IMAC Holdings, Inc. (NASDAQ: BACK), today announces the appointment of Faith Zaslavsky as its new Chief Executive Officer. Ms. Zaslavsky, who has served as the Company’s President and Chief Operating Officer since December 2022, will assume this role effective June 26, 2023, replacing Mick Ruxin, M.D., who will transition to Theralink’s Chief Medical Officer.

[carusso]

They have a great concept, but any RS to get into NASD would put them in the trash bin in investors eyes. They should improve pps via organic growth and merit-based recognition. I hope the merger with IMAC (BACK) improves their situation. Obviously they think so.

[learningcurve2020]

Fairytales.

[carusso]

No one needs NASD to get to $1.